サマリー

希少疾病用医薬品の世界市場 2023-2027
Technavioは、希少疾病用医薬品市場をモニターしており、2022年から2027年の間に1708億ドル、予測期間中のCAGRは14.02%で加速して成長すると予測しています。当レポートでは、オーファンドラッグ市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、強力なパイプラインと最近の医薬品承認、希少疾患の発生率の上昇、希少医薬品開発のためのインセンティブの利用可能性によって牽引されています。
Technavioのオーファンドラッグ市場は以下のようにセグメント化されています：
流通チャネル別
- 病院薬局
- スペシャリティファーマシー
- リテールファーマシー
- その他
製品別
- バイオロジクス
- 非生物学的製剤
地理的景観別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、今後数年間のオーファンドラッグ市場の成長を促進する主な理由の一つとして、アライアンス、パートナーシップ、M&Aへの戦略的な注力を挙げています。また、併用療法や新規ターゲットの出現、遺伝子検査やタンパク質バイオマーカーの需要の高まりは、市場の大きな需要につながると考えられます。
Technavioは、主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。希少疾病用医薬品市場に関する弊社のレポートは、以下の分野をカバーしています：
- 希少疾病用医薬品市場のサイジング
- オーファンドラッグ市場予測
- オーファンドラッグ市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上させることを目的としており、これに沿って、本レポートでは、AbbVie Inc.を含むいくつかの主要なオーファンドラッグ市場ベンダーについて詳細に分析しています、Alnylam Pharmaceuticals Inc.、Astellas Pharma Inc.、AstraZeneca Plc、bluebird bio Inc.、Bristol Myers Squibb Co.、CSL Ltd., F. Hoffmann La Roche Ltd.、Gilead Sciences Inc., GlaxoSmithKline Plc, Ipsen Pharma, Johnson and Johnson Services Inc, Merck and Co.Inc.、Novartis AG、Novo Nordisk AS、Pfizer Inc.、Ractigen Therapeutics、Sanofi SA、Takeda Pharmaceutical Co.Ltd.、Vertex Pharmaceuticals Inc.の6社です。また、オーファンドラッグ市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要な参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/orphan-drugs-market-size-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global orphan drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global orphan drugs market 2017 - 2021 ($ billion)
o 4.2 Distributed Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distributed Channel Segment 2017 - 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacy - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o 6.4 Specialty pharmacy - Market size and forecast 2022-2027
o Exhibit 38: Chart on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
o 6.5 Retail pharmacy - Market size and forecast 2022-2027
o Exhibit 42: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Distribution Channel
o Exhibit 50: Market opportunity by Distribution Channel ($ billion)
o Exhibit 51: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 52: Chart on Product - Market share 2022-2027 (%)
o Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 54: Chart on Comparison by Product
o Exhibit 55: Data Table on Comparison by Product
o 7.3 Biologics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Biologics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
o 7.4 Non-biologics - Market size and forecast 2022-2027
o Exhibit 60: Chart on Non-biologics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Non-biologics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Non-biologics - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Non-biologics - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 64: Market opportunity by Product ($ billion)
o Exhibit 65: Data Table on Market opportunity by Product ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Germany - Market size and forecast 2022-2027
o Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Alnylam Pharmaceuticals Inc.
o Exhibit 119: Alnylam Pharmaceuticals Inc. - Overview
o Exhibit 120: Alnylam Pharmaceuticals Inc. - Product / Service
o Exhibit 121: Alnylam Pharmaceuticals Inc. - Key news
o Exhibit 122: Alnylam Pharmaceuticals Inc. - Key offerings
o 12.5 Astellas Pharma Inc.
o Exhibit 123: Astellas Pharma Inc. - Overview
o Exhibit 124: Astellas Pharma Inc. - Product / Service
o Exhibit 125: Astellas Pharma Inc. - Key news
o Exhibit 126: Astellas Pharma Inc. - Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 127: AstraZeneca Plc - Overview
o Exhibit 128: AstraZeneca Plc - Product / Service
o Exhibit 129: AstraZeneca Plc - Key news
o Exhibit 130: AstraZeneca Plc - Key offerings
o 12.7 bluebird bio Inc.
o Exhibit 131: bluebird bio Inc. - Overview
o Exhibit 132: bluebird bio Inc. - Product / Service
o Exhibit 133: bluebird bio Inc. - Key offerings
o 12.8 Bristol Myers Squibb Co.
o Exhibit 134: Bristol Myers Squibb Co. - Overview
o Exhibit 135: Bristol Myers Squibb Co. - Product / Service
o Exhibit 136: Bristol Myers Squibb Co. - Key news
o Exhibit 137: Bristol Myers Squibb Co. - Key offerings
o 12.9 CSL Ltd.
o Exhibit 138: CSL Ltd. - Overview
o Exhibit 139: CSL Ltd. - Business segments
o Exhibit 140: CSL Ltd. - Key news
o Exhibit 141: CSL Ltd. - Key offerings
o Exhibit 142: CSL Ltd. - Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 Gilead Sciences Inc.
o Exhibit 148: Gilead Sciences Inc. - Overview
o Exhibit 149: Gilead Sciences Inc. - Product / Service
o Exhibit 150: Gilead Sciences Inc. - Key news
o Exhibit 151: Gilead Sciences Inc. - Key offerings
o 12.12 GlaxoSmithKline Plc
o Exhibit 152: GlaxoSmithKline Plc - Overview
o Exhibit 153: GlaxoSmithKline Plc - Business segments
o Exhibit 154: GlaxoSmithKline Plc - Key news
o Exhibit 155: GlaxoSmithKline Plc - Key offerings
o Exhibit 156: GlaxoSmithKline Plc - Segment focus
o 12.13 Ipsen Pharma
o Exhibit 157: Ipsen Pharma - Overview
o Exhibit 158: Ipsen Pharma - Business segments
o Exhibit 159: Ipsen Pharma - Key offerings
o Exhibit 160: Ipsen Pharma - Segment focus
o 12.14 Johnson and Johnson Services Inc.
o Exhibit 161: Johnson and Johnson Services Inc. - Overview
o Exhibit 162: Johnson and Johnson Services Inc. - Business segments
o Exhibit 163: Johnson and Johnson Services Inc. - Key news
o Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
o 12.15 Merck and Co. Inc.
o Exhibit 166: Merck and Co. Inc. - Overview
o Exhibit 167: Merck and Co. Inc. - Business segments
o Exhibit 168: Merck and Co. Inc. - Key news
o Exhibit 169: Merck and Co. Inc. - Key offerings
o Exhibit 170: Merck and Co. Inc. - Segment focus
o 12.16 Novartis AG
o Exhibit 171: Novartis AG - Overview
o Exhibit 172: Novartis AG - Business segments
o Exhibit 173: Novartis AG - Key offerings
o Exhibit 174: Novartis AG - Segment focus
o 12.17 Ractigen Therapeutics
o Exhibit 175: Ractigen Therapeutics - Overview
o Exhibit 176: Ractigen Therapeutics - Product / Service
o Exhibit 177: Ractigen Therapeutics - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global orphan drugs market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Distributed Channel Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Distribution Channel ($ billion)
Exhibits51: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits52: Chart on Product - Market share 2022-2027 (%)
Exhibits53: Data Table on Product - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Non-biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Non-biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Non-biologics - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Non-biologics - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Product ($ billion)
Exhibits65: Data Table on Market opportunity by Product ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Alnylam Pharmaceuticals Inc. - Overview
Exhibits120: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibits121: Alnylam Pharmaceuticals Inc. - Key news
Exhibits122: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits123: Astellas Pharma Inc. - Overview
Exhibits124: Astellas Pharma Inc. - Product / Service
Exhibits125: Astellas Pharma Inc. - Key news
Exhibits126: Astellas Pharma Inc. - Key offerings
Exhibits127: AstraZeneca Plc - Overview
Exhibits128: AstraZeneca Plc - Product / Service
Exhibits129: AstraZeneca Plc - Key news
Exhibits130: AstraZeneca Plc - Key offerings
Exhibits131: bluebird bio Inc. - Overview
Exhibits132: bluebird bio Inc. - Product / Service
Exhibits133: bluebird bio Inc. - Key offerings
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: CSL Ltd. - Overview
Exhibits139: CSL Ltd. - Business segments
Exhibits140: CSL Ltd. - Key news
Exhibits141: CSL Ltd. - Key offerings
Exhibits142: CSL Ltd. - Segment focus
Exhibits143: F. Hoffmann La Roche Ltd. - Overview
Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits145: F. Hoffmann La Roche Ltd. - Key news
Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits148: Gilead Sciences Inc. - Overview
Exhibits149: Gilead Sciences Inc. - Product / Service
Exhibits150: Gilead Sciences Inc. - Key news
Exhibits151: Gilead Sciences Inc. - Key offerings
Exhibits152: GlaxoSmithKline Plc - Overview
Exhibits153: GlaxoSmithKline Plc - Business segments
Exhibits154: GlaxoSmithKline Plc - Key news
Exhibits155: GlaxoSmithKline Plc - Key offerings
Exhibits156: GlaxoSmithKline Plc - Segment focus
Exhibits157: Ipsen Pharma - Overview
Exhibits158: Ipsen Pharma - Business segments
Exhibits159: Ipsen Pharma - Key offerings
Exhibits160: Ipsen Pharma - Segment focus
Exhibits161: Johnson and Johnson Services Inc. - Overview
Exhibits162: Johnson and Johnson Services Inc. - Business segments
Exhibits163: Johnson and Johnson Services Inc. - Key news
Exhibits164: Johnson and Johnson Services Inc. - Key offerings
Exhibits165: Johnson and Johnson Services Inc. - Segment focus
Exhibits166: Merck and Co. Inc. - Overview
Exhibits167: Merck and Co. Inc. - Business segments
Exhibits168: Merck and Co. Inc. - Key news
Exhibits169: Merck and Co. Inc. - Key offerings
Exhibits170: Merck and Co. Inc. - Segment focus
Exhibits171: Novartis AG - Overview
Exhibits172: Novartis AG - Business segments
Exhibits173: Novartis AG - Key offerings
Exhibits174: Novartis AG - Segment focus
Exhibits175: Ractigen Therapeutics - Overview
Exhibits176: Ractigen Therapeutics - Product / Service
Exhibits177: Ractigen Therapeutics - Key offerings
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations